OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Multidisciplinary Approach to Coronavirus Disease (COVID-19)
Aliye Gediz Ertürk, Arzu Şahin, Ebru Batı Ay, et al.
Molecules (2021) Vol. 26, Iss. 12, pp. 3526-3526
Open Access | Times Cited: 19

Showing 19 citing articles:

From imbalance to impairment: the central role of reactive oxygen species in oxidative stress-induced disorders and therapeutic exploration
Sheryar Afzal, Aimi Syamima Abdul Manap, Ali Attiq, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 76

Are Nutraceuticals Effective in COVID-19 and Post-COVID Prevention and Treatment?
Alessia Catalano, Domenico Iacopetta, Jessica Ceramella, et al.
Foods (2022) Vol. 11, Iss. 18, pp. 2884-2884
Open Access | Times Cited: 34

Mannosylated polyethylenimine-cholesterol-based nanoparticles for targeted delivery of minicircle DNA vaccine against COVID-19 to antigen-presenting cells
Dalinda Eusébio, Milan Paul, Swati Biswas, et al.
International Journal of Pharmaceutics (2024) Vol. 654, pp. 123959-123959
Open Access | Times Cited: 2

mRNA-Based Nanomedicinal Products to Address Corneal Inflammation by Interleukin-10 Supplementation
Itziar Gómez-Aguado, Julen Rodríguez-Castejón, Marina Beraza-Millor, et al.
Pharmaceutics (2021) Vol. 13, Iss. 9, pp. 1472-1472
Open Access | Times Cited: 15

mRNA delivery technologies: Toward clinical translation
Itziar Gómez-Aguado, Julen Rodríguez-Castejón, Marina Beraza-Millor, et al.
International review of cell and molecular biology (2022), pp. 207-293
Closed Access | Times Cited: 10

Stem cell therapy: a novel approach against emerging and re-emerging viral infections with special reference to SARS-CoV-2
Vishal Khandelwal, Tarubala Sharma, Saurabh Gupta, et al.
Molecular Biology Reports (2022) Vol. 50, Iss. 3, pp. 2663-2683
Open Access | Times Cited: 7

Epidemiologic characteristics of SARS-CoV-2 in Wuhan, other regions of China, and globally based on data gathered from January 2020 to February 2021
Song Fengjiao, Xiaodong Li, Jian Li, et al.
Medicine (2022) Vol. 101, Iss. 32, pp. e30019-e30019
Open Access | Times Cited: 6

Outcomes comparison between the first and the subsequent SARS-CoV-2 waves – a systematic review and meta-analysis
Túlio Caldonazo, Ricardo Esper Treml, Felipe Souza Lima Vianna, et al.
Multidisciplinary Respiratory Medicine (2023) Vol. 18
Open Access | Times Cited: 2

Predictors of 2-year mortality in geriatric patients hospitalized with COVID-19 in Türkiye: a retrospective cohort study
Bahar Bektan Kanat, Gülru Ulugerger Avcı, Osman Faruk Bayramlar, et al.
Biomarkers in Medicine (2024) Vol. 18, Iss. 10-12, pp. 555-565
Closed Access

APPLICATION OF GENE ENGINEERING IN THE TREATMENT OF PATIENTS WITH COVID-19
В.Д. Москалюк, I.V. Balaniuk, С.Р. Меленко, et al.
Medical Science of Ukraine (MSU) (2024) Vol. 20, Iss. 1, pp. 123-129
Open Access

Stem Cell Therapy for SARS-CoV-2 and Influenza Virus Infections
Neelabh Datta
BIO Integration (2024) Vol. 5, Iss. 1
Open Access

Recent Advances in N-Heterocycles for COVID-19 Treatment - A Mini Review
Monica Dinodia
Medicinal Chemistry (2023) Vol. 19, Iss. 8, pp. 717-729
Closed Access | Times Cited: 1

Multidisciplinary Effort and Integrative Preparedness: A Lesson for the Foreseen Multivariate COVID-19 Pandemic Flare-Up
Ashagrachew Tewabe Yayehrad, Ebrahim Abdela Siraj, Dawit Kumilachew Yimenu, et al.
Journal of Multidisciplinary Healthcare (2021) Vol. Volume 14, pp. 2905-2921
Open Access | Times Cited: 3

An Updated and Focused Review on Heterocyclic Inhibitors for SARSCoV and SARS-CoV-2 3CLpro
Ozair Alam, Ajay Manaithiya, Shruti Mittal, et al.
Mini-Reviews in Medicinal Chemistry (2022) Vol. 23, Iss. 5, pp. 576-632
Closed Access | Times Cited: 2

Microbiological screening tests for SARS-CoV-2 in the first hour since the hospital admission: A reliable tool for enhancing the safety of pediatric care
Giuseppe Vetrugno, Simone Grassi, Francesco Clemente, et al.
Frontiers in Pediatrics (2022) Vol. 10
Open Access | Times Cited: 2

COVID-19-related mortality in Texas border counties vs non-border counties
Amna Obaid, Seyed Khalafi, Alok Dwivedi, et al.
Journal of Investigative Medicine (2023) Vol. 72, Iss. 2, pp. 211-219
Closed Access

Enfermedad hepatobiliar en la era COVID-19
Juan Carlos Restrepo
Hepatología (2022), pp. 129-130
Open Access

ЗАСТОСУВАННЯ ГЕННОІНЖЕНЕРНИХ ЗАСОБІВ У ЛІКУВАННІ ХВОРИХ НА COVID-19
В. Д. Москалюк, Borys Sirota
Інфекційні хвороби (2022), Iss. 2, pp. 82-87
Open Access

Page 1

Scroll to top